Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer. Gobel A, Zinna VM, Dell'Endice S, Jaschke N, et al. BMC Cancer 2020;20:703.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gobel A, Zinna VM, Dell'Endice S, Jaschke N, et al. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer. BMC Cancer 2020;20:703.
PMID: 32727400